Next Med
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
NEWS
Clínic-IDIBAPS: Leading the Mediterranean Expansion of Academic CAR-T Therapy in MILenARI project
As the leader of the MILenARI project, Clínic-IDIBAPS stands at the forefront of academic CAR‑T innovation. The Barcelona team developed the first academic CAR‑T therapy authorized, now being scaled for international deployment.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
MILenARI: a European project to democratize access to CAR-T therapy in the Mediterranean
On Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held its inaugural meeting online, with the participation of all partners and representatives of the Interreg NEXT MED program, which funds the project. The meeting was very fruitful and marked the start of an initiative with a clear mission: to make CAR-T therapy accessible to more patients in the Mediterranean basin. The project has a total funding of €2,498,88.15, 89% of which is covered by the European Union.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region